Impact of aging on immature platelet count and its relationship with coronary artery disease

被引:7
作者
Verdoia, Monica [1 ]
Nardin, Matteo [1 ,2 ]
Negro, Federica [1 ]
Tonon, Francesco [1 ]
Gioscia, Rocco [1 ]
Rolla, Roberta [3 ]
De Luca, Giuseppe [1 ]
机构
[1] Eastern Piedmont Univ, Dept Cardiol, Osped Maggiore Carita, Novara, Italy
[2] Univ Brescia, Dept Med, ASST Spedali Civili, Brescia, Italy
[3] Eastern Piedmont Univ, Dept Clin Chem, Osped Maggiore Carita, Novara, Italy
关键词
Coronary artery disease; elderly; immature platelet count; reticulated platelets; CIRCULATING RETICULATED PLATELETS; ELEVATION MYOCARDIAL-INFARCTION; DUAL ANTIPLATELET THERAPY; ELDERLY-PATIENTS; ADVANCED AGE; PRIMARY ANGIOPLASTY; REACTIVITY; MORTALITY; VOLUME; CLOPIDOGREL;
D O I
10.1080/09537104.2020.1714572
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Despite the fact that elderly patients represent a prevalent and challenging population in the current practice, few data exist on the impact of platelet parameters on cardiovascular risk in these patients. Therefore, the aim of the present study was to evaluate the impact of age on the immature platelet count (IPC) and their relationship with CAD. We included a total of 2236 consecutive patients undergoing coronary angiography in a single center. Elderly patients (age >= 75 years) were 756 (33.7%). IPC was measured at admission. Elderly patients were more often females (p < .001), with lower BMI and prevalence of smokers (p < .001), and a more complex cardiovascular risk profile and coronary disease (p = .02). Platelet count decreased with aging (p = .05), whereas no difference in the mean IPC was found between patients < or >= 75 years. In fact, advanced age did not emerge as an independent predictor of IPC above III tertile (>= 8.6*10<^>6/ml), (adjusted OR[95%CI] = 0.97[0.78-1.21], p = .79). When considering elderly patients according to tertiles values of IPC (<5.1,5.1-8.59; >= 8.6*10<^>6/ml), we found no impact of IPC on the prevalence of CAD (81.1% vs 84.5% vs 81.5%, p = .92; adjusted OR[95%CI] = 1.08[0.67-1.72], p = .75) and its extent (37.7% vs 34.5% vs 40.2%, p = .57; adjusted OR[95%CI] = 1.22[0.85-1.73], p = .28). However, we observed a higher rate of calcified and type C lesions in elderly patients with higher IPC (p = .03 and p < .001, respectively). Therefore, advanced age is not associated with higher immature platelet count and the prevalence and severity of CAD. Moreover, IPC does not contribute to explain the higher prevalence and extent of coronary artery disease observed in elderly patients.
引用
收藏
页码:1060 / 1068
页数:9
相关论文
共 45 条
  • [1] Frailty Assessment in the Cardiovascular Care of Older Adults
    Afilalo, Jonathan
    Alexander, Karen P.
    Mack, Michael J.
    Maurer, Mathew S.
    Green, Philip
    Allen, Larry A.
    Popma, Jeffrey J.
    Ferrucci, Luigi
    Forman, Daniel E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (08) : 747 - 762
  • [2] Acute coronary care in the elderly, Part II - ST-segment-elevation myocardial infarction - A scientific statement for healthcare professionals from the American Heart Association council on clinical cardiology - In collaboration with the Society of Geriatric Cardiology
    Alexander, Karen P.
    Newby, L. Kristin
    Armstrong, Paul W.
    Cannon, Christopher P.
    Gibler, W. Brian
    Rich, Michael W.
    Van de Werf, Frans
    White, Harvey D.
    Weaver, W. Douglas
    Naylor, Mary D.
    Gore, Joel M.
    Krumholz, Harlan M.
    Ohman, E. Magnus
    [J]. CIRCULATION, 2007, 115 (19) : 2570 - 2589
  • [3] Five-Year Follow-Up of Patients Treated for Coronary Artery Disease in the Face of an Increasing Burden of Co-Morbidity and Disease Complexity (from the NHLBI Dynamic Registry)
    Bortnick, Anna E.
    Epps, Kelly C.
    Selzer, Faith
    Anwaruddin, Saif
    Marroquin, Oscar C.
    Srinivas, Vankeepuram
    Holper, Elizabeth M.
    Wilensky, Robert L.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (04) : 573 - 579
  • [4] Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial
    Cayla, Guillaume
    Cuisset, Thomas
    Silvain, Johanne
    Leclercq, Florence
    Manzo-Silberman, Stephane
    Saint-Etienne, Christophe
    Delarche, Nicolas
    Bellemain-Appaix, Anne
    Range, Gregoire
    El Mahmoud, Rami
    Carrie, Didier
    Belle, Loic
    Souteyrand, Geraud
    Aubry, Pierre
    Sabouret, Pierre
    du Fretay, Xavier Halna
    Beygui, Farzin
    Bonnet, Jean-Louis
    Lattuca, Benoit
    Pouillot, Christophe
    Varenne, Olivier
    Boueri, Ziad
    Van Belle, Eric
    Henry, Patrick
    Motreff, Pascal
    Elhadad, Simon
    Salem, Joe-Elie
    Abtan, Jeremie
    Rousseau, Helene
    Collet, Jean-Philippe
    Vicaut, Eric
    Montalescot, Gilles
    [J]. LANCET, 2016, 388 (10055) : 2015 - 2022
  • [5] Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries
    Danchin, Nicolas
    Lettino, Maddalena
    Zeymer, Uwe
    Widimsky, Petr
    Bardaji, Alfredo
    Barrabes, Jose A.
    Cequier, Angel
    Claeys, Marc J.
    De Luca, Leonardo
    Doerler, Jakob
    Erlinge, David
    Erne, Paul
    Goldstein, Patrick
    Koul, Sasha M.
    Lemesle, Gilles
    Luscher, Thomas F.
    Matter, Christian M.
    Montalescot, Gilles
    Radovanovic, Dragana
    Lopez Sendon, Jose
    Tousek, Petr
    Weidinger, Franz
    Weston, Clive F. M.
    Zaman, Azfar
    Andell, Pontus
    Li, Jin
    Jukema, J. Wouter
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2016, 2 (03) : 152 - 167
  • [6] Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty
    De Luca, G
    van't Hof, AWJ
    Ottervanger, JP
    Hoorntje, JCA
    Gosselink, ATM
    Dambrink, JHE
    de Boer, MJ
    Suryapranata, H
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (07) : 662 - 666
  • [7] Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study
    De Luca, G.
    Secco, G. G.
    Santagostino, M.
    Venegoni, L.
    Iorio, S.
    Cassetti, E.
    Verdoia, M.
    Coppo, L.
    Di Mario, C.
    Bellomo, G.
    Marino, P.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (05) : 426 - 433
  • [8] Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors
    De Luca, Giuseppe
    van't Hof, Arnoud W. J.
    Huber, Kurt
    Gibson, C. Michael
    Bellandi, Francesco
    Arntz, Hans-Richard
    Maioli, Mauro
    Noc, Marko
    Zorman, Simona
    Secco, Gioel Gabrio
    Zeymer, Uwe
    Mesquita Gabriel, H.
    Emre, Ayse
    Cutlip, Donald
    Rakowski, Tomasz
    Gyongyosi, Maryann
    Dudek, Dariusz
    [J]. HEART AND VESSELS, 2014, 29 (01) : 15 - 20
  • [9] Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients
    De Luca, Giuseppe
    Verdoia, Monica
    Cassetti, Ettore
    Schaffer, Alon
    Di Giovine, Gabriella
    Bertoni, Alessandra
    Di Vito, Clara
    Sampietro, Sara
    Aimaretti, Gianluca
    Bellomo, Giorgio
    Marino, Paolo
    Sinigaglia, Fabiola
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (06) : 619 - 624
  • [10] Impact of Age on Long-Term Outcome After Primary Angioplasty With Bare-Metal or Drug-Eluting Stent (from the DESERT Cooperation)
    De Luca, Giuseppe
    Dirksen, Maurits T.
    Spaulding, Christian
    Kelbaek, Henning
    Schalij, Martin
    Thuesen, Leif
    van der Hoeven, Bas
    Vink, Marteen A.
    Kaiser, Christoph
    Musto, Carmine
    Chechi, Tania
    Spaziani, Gaia
    de la Llera, Luis Salvador Diaz
    Pasceri, Vincenzo
    Di Lorenzo, Emilio
    Violini, Roberto
    Suryapranata, Harry
    Stone, Gregg W.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (02) : 181 - 186